2-Deoxy-D-glucose and siRNA suppresses the activation of ADAM10 and ADAM17, down-regulates mesenchymal properties, reduces the secretion of EMT-associated cytokine, and renders the tumor susceptible to anti-cancer drug treatment [152,153,154]. Here, ADAM17 is linked to neoplasm.